Cargando…

Erianin: A phytoestrogen with therapeutic potential

Erianin, a phytoestrogen with therapeutic potential, is one of the major active components of Dendrobll caulis. Erianin has a variety of pharmacological effects, such as anti-tumor, anti-inflammatory, anti-diabetic retinopathy, anti-psoriasis, and antibacterial effects. Especially, in regard to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Gangmin, Zhang, Huiqiong, Lai, Hui, Liang, Gang, Huang, Jiang, Zhao, Fulan, Xie, Xiaofang, Peng, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440559/
https://www.ncbi.nlm.nih.gov/pubmed/37608888
http://dx.doi.org/10.3389/fphar.2023.1197056
_version_ 1785093182396039168
author Li, Gangmin
Zhang, Huiqiong
Lai, Hui
Liang, Gang
Huang, Jiang
Zhao, Fulan
Xie, Xiaofang
Peng, Cheng
author_facet Li, Gangmin
Zhang, Huiqiong
Lai, Hui
Liang, Gang
Huang, Jiang
Zhao, Fulan
Xie, Xiaofang
Peng, Cheng
author_sort Li, Gangmin
collection PubMed
description Erianin, a phytoestrogen with therapeutic potential, is one of the major active components of Dendrobll caulis. Erianin has a variety of pharmacological effects, such as anti-tumor, anti-inflammatory, anti-diabetic retinopathy, anti-psoriasis, and antibacterial effects. Especially, in regard to the anti-tumor effect of erianin, the underlying molecular mechanism has been partly clarified. In fact, the numerous pharmacological actions of erianin are complex and interrelated, mainly including ERK1/2, PI3K/Akt, JAK2/STAT3, HIF-1α/PD-L1, PPT1/mTOR, JNK/c-Jun, and p38 MAPK signal pathway. However, on account of the poor water solubility and the low bioavailability of erianin, greatly affected and limited its further development and application. And it is worthwhile and meaningful to explore more extensive pharmacological effects and mechanisms, clarify pharmacokinetics, and synthesize the derivatives of erianin. Conclusively, in this paper, the pharmacological effects of erianin and its mechanism, pharmacokinetics, and derivatives studies were reviewed, in order to provide a reference for the development and application of erianin.
format Online
Article
Text
id pubmed-10440559
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104405592023-08-22 Erianin: A phytoestrogen with therapeutic potential Li, Gangmin Zhang, Huiqiong Lai, Hui Liang, Gang Huang, Jiang Zhao, Fulan Xie, Xiaofang Peng, Cheng Front Pharmacol Pharmacology Erianin, a phytoestrogen with therapeutic potential, is one of the major active components of Dendrobll caulis. Erianin has a variety of pharmacological effects, such as anti-tumor, anti-inflammatory, anti-diabetic retinopathy, anti-psoriasis, and antibacterial effects. Especially, in regard to the anti-tumor effect of erianin, the underlying molecular mechanism has been partly clarified. In fact, the numerous pharmacological actions of erianin are complex and interrelated, mainly including ERK1/2, PI3K/Akt, JAK2/STAT3, HIF-1α/PD-L1, PPT1/mTOR, JNK/c-Jun, and p38 MAPK signal pathway. However, on account of the poor water solubility and the low bioavailability of erianin, greatly affected and limited its further development and application. And it is worthwhile and meaningful to explore more extensive pharmacological effects and mechanisms, clarify pharmacokinetics, and synthesize the derivatives of erianin. Conclusively, in this paper, the pharmacological effects of erianin and its mechanism, pharmacokinetics, and derivatives studies were reviewed, in order to provide a reference for the development and application of erianin. Frontiers Media S.A. 2023-08-07 /pmc/articles/PMC10440559/ /pubmed/37608888 http://dx.doi.org/10.3389/fphar.2023.1197056 Text en Copyright © 2023 Li, Zhang, Lai, Liang, Huang, Zhao, Xie and Peng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Li, Gangmin
Zhang, Huiqiong
Lai, Hui
Liang, Gang
Huang, Jiang
Zhao, Fulan
Xie, Xiaofang
Peng, Cheng
Erianin: A phytoestrogen with therapeutic potential
title Erianin: A phytoestrogen with therapeutic potential
title_full Erianin: A phytoestrogen with therapeutic potential
title_fullStr Erianin: A phytoestrogen with therapeutic potential
title_full_unstemmed Erianin: A phytoestrogen with therapeutic potential
title_short Erianin: A phytoestrogen with therapeutic potential
title_sort erianin: a phytoestrogen with therapeutic potential
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440559/
https://www.ncbi.nlm.nih.gov/pubmed/37608888
http://dx.doi.org/10.3389/fphar.2023.1197056
work_keys_str_mv AT ligangmin erianinaphytoestrogenwiththerapeuticpotential
AT zhanghuiqiong erianinaphytoestrogenwiththerapeuticpotential
AT laihui erianinaphytoestrogenwiththerapeuticpotential
AT lianggang erianinaphytoestrogenwiththerapeuticpotential
AT huangjiang erianinaphytoestrogenwiththerapeuticpotential
AT zhaofulan erianinaphytoestrogenwiththerapeuticpotential
AT xiexiaofang erianinaphytoestrogenwiththerapeuticpotential
AT pengcheng erianinaphytoestrogenwiththerapeuticpotential